Krogerus acted alongside Swedish law firm Vinge for CELLINK AB (publ), the leading bioconvergence company, on CELLINK's acquisition of Ginolis Oy, a Finnish company focusing on diagnostics automation and advanced robotics solutions for medical and diagnostic industries, in a transaction valued at EUR 70 million. Forty per cent of the purchase price will be paid by issuance of shares in CELLINK and the remainder will be paid in cash. Completion of the transaction is expected to occur by 1 March 2021.
The Krogerus team was led by Partner Marcus Möller and he was assisted by Associates Andreas Brink, Maria Naukkarinen, Anna Salokangas, Ilari Sarja and Laura Äijälä.
Team
Latest references
View all referencesKrogerus advises Meridiam in a cooperative rental project with the City of Espoo
Krogerus advises Northern Horizon on Hämeenlinna forward funding transaction
Krogerus advised OP Corporate Bank plc on a EUR 60 million senior financing package for Boreo Plc